Search results for: 'cases detect learning'

Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

Stroke remains the leading cause of long-term disability and mortality worldwide, with every minute of delayed diagnosis resulting in irreversible neuronal damage. Recent advancements in AI-powered imaging and portable diagnostic devices are transforming the stroke diagnosis landscape by enabling rapid, decentralized, and data-driven assessment. Th...

The COVID-19 pandemic and the shift toward value-based care have highlighted the need for more flexible and resilient healthcare systems, creating opportunities for innovative business models. Several challenges, such as personnel burnout, the lack of experienced staff, inflation leading to increased care costs, healthcare accessibility disparities...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

Brazil’s telemedicine market is likely to increase from $495.3 million in 2015 to $743.8 million in 2017 whereas the mHealth market revenue will grow from $446.8 million to $1.43 billion over the same period. Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine appl...

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

This research study analyzes the U.S. Computer Aided Detection (CAD) market from 2002 to 2012 with a base year of 2005. The main chapters of the report include an executive summary, overview of the CAD equipment market and in depth analysis of the CAD market by application type.

30 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Medical Imaging Artificial Intelligence Market, Forecast to 2022

Emerging Use Cases, Revenue, and Industry Savings Potential

Infographics

×

Key Issues Addressed

Artificial Intelligence (AI) for medical imaging is a reality now. While image analysis applications are the most advanced, adopted, and well-known, there are several other use cases which are probably not as well-known or thought of. Applications across the imaging workflow, beginning with the ordering of images by a physician, scheduling of the s...